Medical News

RSS

World's smallest and lightest microscope for telemedicine applications

Aydogan Ozcan, whose invention of a novel lensless imaging technology for use in telemedicine could radically transform global health care, has now taken his work a step further ― or tinier: The UCLA engineer has created a miniature microscope, the world's smallest and lightest for telemedicine applications.

23 Apr 2010

New USG strategy to combat malaria globally

In conjunction with World Malaria Day, and in accordance with the requirements of the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis and Malaria Reauthorization Act of 2008 (Lantos-Hyde), the U.S. Government, through the President's Malaria Initiative, today released a comprehensive strategy to combat malaria globally.

23 Apr 2010

Detroit-area resident pleads guilty in fraudulent medical testing scheme

Detroit-area resident Melvin Young pleaded guilty today to engaging in a fraudulent medical testing scheme, announced the Departments of Justice and Health and Human Services (HHS).

23 Apr 2010

Possibility of Mexican health care for Americans discussed

Participants at a conference held in San Diego Wednesday discussed the possibility of sending US patients across the border to Mexico for health care. The option is said to be possible, but probably still far away, participants "said that a range of legislative and regulatory changes are needed."

23 Apr 2010

Travel Toward Wellness specializes in women's wellness travel for cancer survivors

Cancer survivors often describe their experience as a "journey." Now Nancy Parker, veteran corporate executive and breast cancer survivor, is taking other survivors on a more joyful journey. Her company, Travel Toward Wellness, is filling a unique travel niche, specializing in girlfriend getaways and women's wellness travel for cancer survivors.

23 Apr 2010

Better diagnostics in prostate cancer needed

A flurry of confusing research about the benefits of PSA testing has left many men and their physicians reticent to use a test that may be life-saving, says a panel of prostate cancer experts. The experts who gathered on Capitol Hill in Washington on Tuesday agreed that PSA testing, while not cancer-specific, is one of the best available tools for early detection of a cancer that kills 27,000 American men each year.

23 Apr 2010

Treating OSA in truck drivers lowers healthcare costs and disability rates: Study

For commercial motor vehicle drivers with obstructive sleep apnea, effective treatment lowers healthcare costs and disability rates, reports a study in the May Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine.

23 Apr 2010

Researchers produce stem cells from eggs of aging mice for regenerative medicine

Researchers at NYU Langone Medical Center have created stem cells from the eggs of aging mice that could be used for reproductive purposes and regenerative medicine. The study, published in April issue of Aging Cell, found that even though the eggs from older females were slightly less efficient at making stem cells than those from younger females, the capacity to create stem cells was sustained.

23 Apr 2010

Hospital for Special Care launches ALS Clinical Trials Unit at Neuromuscular Center

Hospital for Special Care announced today the launch of the region's first Amyotrophic Lateral Sclerosis (ALS) Clinical Trials Unit at its Neuromuscular Center. The new unit will be headed by Jinsy A. Andrews, M.D., a physician researcher recruited from Columbia University. Dr. Andrews, Director of Research & Clinical Trials Unit, Hospital for Special Care, specializes in neuromuscular research and will facilitate the hospital's first clinical trial for ALS upon her arrival.

23 Apr 2010

pHase Pharmaceuticals launches new drug development company

pHase Pharmaceuticals, LLC announces the launch of its new drug development company. pHase Pharmaceuticals is led by a cohesive team of drug development experts who have extensive experience bringing new drugs to market and garnering FDA approval.

23 Apr 2010

OXiGENE applies for voluntary delisting from SSE, continues to be listed on NASDAQ

OXiGENE, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, today announced that it has applied for the voluntary delisting of OXiGENE common shares from the Stockholm Stock Exchange (SSE). The company will continue to be listed on the NASDAQ Global Markets exchange.

23 Apr 2010

Omnibus bill aims to improve women's services at VA health care facilities, support caregivers

Several of The American Legion's top legislative priorities are wrapped up in S. 1963 – an omnibus bill passed Wednesday by the House of Representatives – that aims to improve women's services at VA health care facilities, provide better support for caregivers of disabled veterans, expand mental health services, reduce homelessness and commit the U.S. government to a number of other initiatives to better serve veterans and their families.

23 Apr 2010

Transposagen Biopharmaceuticals announces new TGEM Rat Model product line

Transposagen Biopharmaceuticals, Inc., based in Lexington, KY, has announced today that it has added 170 genetically modified rats and related biomaterials to its database of laboratory rats with a genetic modification that can mimic a human disease. These animals are used by academic, pharmaceutical, and biotech scientists for drug discovery and development research and will be sold under Transposagen's new TGEM(TM) Rat Models brand.

23 Apr 2010

Minorities, seniors see positives in health law; Worries persist about insurance costs

African Americans are hoping new health will improve their lives, but there's "a debate about whether the coming changes will actually ease the health disparities that black Americans face," NPR reports.

23 Apr 2010

Researchers to measure children with Down syndrome to develop new growth charts

Parents and doctors have known for a long time that children with Down syndrome tend to grow more slowly and are considerably shorter than most other children. But pediatricians needing to record growth milestones at regular office visits have an outdated set of growth charts based on data collected more than 25 years ago.

23 Apr 2010

Poll: Americans confused about new health law

USA Today: "More than half of the nation is confused about President Obama's recently enacted health care law and 56% of Americans say they don't have enough information to understand how the measure will affect them, according to a poll released today by the nonpartisan Kaiser Family Foundation."

23 Apr 2010

Medical Properties Trust closes underwritten public offering of common stock

Medical Properties Trust, Inc. announced today that it closed the sale of its previously announced underwritten public offering of shares of common stock, which included 26 million shares of common stock issued on April 20, 2010 and 3.9 million shares of common stock issued on April 22, 2010 pursuant to the exercise in full of the underwriters' over-allotment option.

23 Apr 2010

Nile Therapeutics prices underwritten public offering of common stock

Nile Therapeutics, Inc., a company focused on the development of novel therapeutics for heart failure patients, announced the pricing of its previously announced underwritten public offering of 6,500,000 units of its securities at a public offering price of $0.70 per unit. Each unit consists of one share of Nile common stock and 0.30 warrants to purchase common stock.

23 Apr 2010

Genentech submits sBLA for Herceptin plus chemotherapy for advanced HER2-positive stomach cancer

Genentech, Inc., a wholly owned member of the Roche Group, announced today that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Herceptin® (trastuzumab) plus chemotherapy in people with advanced, HER2-positive adenocarcinoma of the stomach, including gastroesophageal junction cancer.

23 Apr 2010

Mayo Clinic study finds changes in tissue damage throughout the course of MS

A new Mayo Clinic study has found that the type of tissue damage changes throughout the course of multiple sclerosis. In early relapsing disease stages, the plaques, or areas where the nervous system is inflamed or demyelinated, are predominantly active with distinct heterogeneous patterns of myelin damage.

23 Apr 2010

Medical News

World's smallest and lightest microscope for telemedicine applications

New USG strategy to combat malaria globally

Detroit-area resident pleads guilty in fraudulent medical testing scheme

Possibility of Mexican health care for Americans discussed

Travel Toward Wellness specializes in women's wellness travel for cancer survivors

Better diagnostics in prostate cancer needed

Treating OSA in truck drivers lowers healthcare costs and disability rates: Study

Researchers produce stem cells from eggs of aging mice for regenerative medicine

Hospital for Special Care launches ALS Clinical Trials Unit at Neuromuscular Center

pHase Pharmaceuticals launches new drug development company

OXiGENE applies for voluntary delisting from SSE, continues to be listed on NASDAQ

Omnibus bill aims to improve women's services at VA health care facilities, support caregivers

Transposagen Biopharmaceuticals announces new TGEM Rat Model product line

Minorities, seniors see positives in health law; Worries persist about insurance costs

Researchers to measure children with Down syndrome to develop new growth charts

Poll: Americans confused about new health law

Medical Properties Trust closes underwritten public offering of common stock

Nile Therapeutics prices underwritten public offering of common stock

Genentech submits sBLA for Herceptin plus chemotherapy for advanced HER2-positive stomach cancer

Mayo Clinic study finds changes in tissue damage throughout the course of MS

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News